Search
× Search
Thursday, January 9, 2025

Archived Discussions

Recent member discussions

The Algorithmic Traders' Association prides itself on providing a forum for the publication and dissemination of its members' white papers, research, reflections, works in progress, and other contributions. Please Note that archive searches and some of our members' publications are reserved for members only, so please log in or sign up to gain the most from our members' contributions.

Should the SEC regulate drug sales?

photo

 Robert Jaeger, Wescott Capital

 Saturday, September 17, 2016

Nobody is advocating that, but after reading this article on how pharmaceutical benefit managers (PBWs) keep drug payers (insurers and corporations) as well as drug sellers (pharmacies) in the dark about how much of a spread they make as intermediaries, we concluded that stock exchanges look downright boring.  http://bit.ly/2clv0b0


Print

Please login or register to post comments.

TRADING FUTURES AND OPTIONS INVOLVES SUBSTANTIAL RISK OF LOSS AND IS NOT SUITABLE FOR ALL INVESTORS
Terms Of UsePrivacy StatementCopyright 2018 Algorithmic Traders Association